Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00882388Phase 4Completed
Phase 4, randomised trial of celecoxib in arthritis (5 arms), sponsored by Seoul National University Hospital. Primary endpoint: Light transmittance aggregometry (% of inhibition ADP, collagen) at 7 days. Started Mar 2005; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00882388.